- Home
- MPB vs ARCT Comparison
MPB vs ARCT Comparison
Compare MPB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- ARCT
- Stock Information
- Founded
- MPB 1868
- ARCT 2013
- Country
- MPB United States
- ARCT United States
- Employees
- MPB N/A
- ARCT N/A
- Industry
- MPB Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MPB Finance
- ARCT Health Care
- Exchange
- MPB Nasdaq
- ARCT Nasdaq
- Market Cap
- MPB 525.0M
- ARCT 487.0M
- IPO Year
- MPB N/A
- ARCT N/A
- Fundamental
- Price
- MPB $29.79
- ARCT $17.12
- Analyst Decision
- MPB Buy
- ARCT Strong Buy
- Analyst Count
- MPB 2
- ARCT 7
- Target Price
- MPB $36.00
- ARCT $65.00
- AVG Volume (30 Days)
- MPB 63.1K
- ARCT 348.5K
- Earning Date
- MPB 01-22-2025
- ARCT 03-06-2025
- Dividend Yield
- MPB 2.68%
- ARCT N/A
- EPS Growth
- MPB 14.41
- ARCT N/A
- EPS
- MPB 2.91
- ARCT N/A
- Revenue
- MPB $173,416,000.00
- ARCT $160,399,000.00
- Revenue This Year
- MPB N/A
- ARCT $7.33
- Revenue Next Year
- MPB $19.26
- ARCT $4.71
- P/E Ratio
- MPB $10.27
- ARCT N/A
- Revenue Growth
- MPB 4.93
- ARCT N/A
- 52 Week Low
- MPB $19.20
- ARCT $14.30
- 52 Week High
- MPB $33.87
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- MPB 54.43
- ARCT 48.75
- Support Level
- MPB $28.48
- ARCT $15.82
- Resistance Level
- MPB $30.19
- ARCT $17.93
- Average True Range (ATR)
- MPB 0.65
- ARCT 1.51
- MACD
- MPB 0.30
- ARCT -0.04
- Stochastic Oscillator
- MPB 88.57
- ARCT 23.90
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.